Insulin efsitora alfa

N/A

Report date: 2026/04/08 16:01:38

Base Information

Drug NameInsulin efsitora alfa
Drug Alias NameBasal Insulin-FC - Eli Lilly and CompanyRecombinant insulin - Eli lilly and CompanyLY-3209590
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionPhosphokinases stimulantsProtein-tyrosine kinases inhibitorsOrnithine decarboxylase stimulants
TargetsPhosphokinasesProtein-tyrosine kinasesOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[22] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyLilly Suzhou Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A